Ionis Pharmaceuticals Inc. buy JPMorgan Chase & Co.
Start price
08.10.25
/
50%
€59.76
Target price
08.10.26
€68.81
Performance (%)
-14.39%
Price
21.08.26
€51.16
Summary
This prediction is currently active. The prediction for Ionis Pharmaceuticals Inc. disappoints with a performance of -14.39%. This prediction currently runs until 08.10.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ionis Pharmaceuticals Inc. | 3.395% | 3.395% |
| iShares Core DAX® | -1,28 % | 4,21 % |
| iShares Nasdaq 100 | -3,34 % | -1,74 % |
| iShares Nikkei 225® | -4,29 % | -1,62 % |
| iShares S&P 500 | -2,31 % | -0,10 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Ionis Pharmaceuticals Inc. diskutieren
Ionis Pharmaceuticals (NASDAQ:IONS) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $80.00 price target on the stock, up previously from $49.00.
Ratings data for IONS provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Ionis Pharmaceuticals Inc.
Ionis Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€46.55
03.08.26
03.08.26
€65.92
03.08.27
03.08.27
9.90%
21.08.26
21.08.26
